New drug shows promise for Long-Term control of rare hormone disorder
Disease control
Ongoing
This study looks at the long-term safety of a weekly injection called MBX 2109 for people with hypoparathyroidism, a condition where the body doesn't produce enough parathyroid hormone. Participants are adults who already completed a 12-week treatment in an earlier study. The goa…
Phase: PHASE2 • Sponsor: MBX Biosciences • Aim: Disease control
Last updated May 08, 2026 12:01 UTC